Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01468415
Recruitment Status : Unknown
Verified May 2011 by Assaf-Harofeh Medical Center. Recruitment status was: Recruiting
The American Society of Anesthesiologists Task Force on Management, Chronic Pain section, recommended Phenol neurolysis when other techniques have failed to provide adequate pain control. In this study we sought to Compare the pain relieve on a Lower Back and Limbs obtained from Methylprednisolone and Phenol 8% Treatment given by Trans Sacral Approach. The study includes patients who suffers from a chronic low back and/or limbs pain which were referred to be given epidural as a treatment. Control group receives 80 mg Methylprednisolone while the test group receives phenol 8%.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Inclusion Criteria: -at least 18 years of age;
chronic low back pain of at least 12 weeks duration;
patients which were diagnosed as a candidate for epidural since other techniques have failed to provide adequate pain control
Sciatica due to Lumbar Disc Herniation
Neurogenic Claudication due to Lumbar Spinal Stenosis
patients with unbalanced high blood pressure
patients who can not ley prone
patients who consumes anti-clotting medications
patients with bleeding problems
patients with Diabetes
patients who suffers from chronic non-specific lower back and limb pain